Venetoclax-based salvage therapy achieves high remission rates after 7+3 or low-dose cytarabine
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Flávia Xavier, Fernando de Oliveira, Augusto Alves, João Victor da Cunha, Vitor Monici, Abel Costa, Nadia Cristina Misael
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108700696
Cites:
Cited by:
Related to: